![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 53, 37651-37657, December 31, 1999
From the Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda, Maryland 20892
| |
ABSTRACT |
|---|
|
|
|---|
The P2X purinergic receptor channels (P2XRs)
differ among themselves with respect to the rates of desensitization
during prolonged agonist stimulation. Here we studied the
desensitization of recombinant channels by monitoring the changes in
intracellular free Ca2+ concentration in cells
stimulated with ATP, the native and common agonist for all P2XRs. The
focus in our investigations was on the relevance of the P2XR C terminus
in controlling receptor desensitization. When expressed in GT1 cells,
the P2XRs desensitized with rates characteristic to each receptor
subtype: P2X1R = P2X3R > P2X2bR > P2X4R > P2X2aR > P2X7R. A slow desensitizing
pattern of P2X2aR was mimicked partially by
P2X3R and fully by P2X4R when the six-amino acid sequences of these channels located in the cytoplasmic C terminus
were substituted with the corresponding arginine 371 to proline 376 sequence of P2X2aR. Changing the total net charge in the
six amino acids of P2X4R to a more positive direction also slowed the receptor desensitization. On the other hand, substitution of
arginine 371-proline 376 sequence of P2X2aR with the
corresponding sequences of P2X1R, P2X3R, and
P2X4R increased the rate of receptor desensitization.
Furthermore, heterologous polymerization of wild-type P2X2aR and mutant P2X3R having the C-terminal
six amino acids of P2X2aR at its analogous position
resulted in a functional channel whose desensitization was
significantly delayed. These results suggest that composition of the
C-terminal six-amino acid sequence and its electrostatic force
influence the rate of receptor desensitization.
ATP-gated receptor channels
(P2XRs)1 are expressed in a
number of tissues where they are involved in regulation of a wide
variety of cellular functions, including central and peripheral
neurotransmission, smooth muscle contraction, platelet activation, and
hormone secretion (1-3). The regulation of these functions by the
activated P2XRs requires or is susceptible to local and/or global
changes in intracellular Ca2+ concentration
([Ca2+]i) (3). Binding of extracellular ATP to
P2XRs is associated with a rise in [Ca2+]i, which
is mediated by Ca2+ influx through these channels as well
as by depolarization of cells and activation of voltage-gated
Ca2+ channels. The pattern of [Ca2+]i
signaling by native P2XRs is highly variable, depending on the cell
type examined (3). In contrast to other Ca2+-conducting
channels, however, the relevant structural base of the P2XRs
contributing to the control of [Ca2+]i signaling
function has not been completely elucidated.
Using molecular cloning techniques, seven subunits of P2XRs have been
obtained so far and are named P2X1R to P2X7R
(4-10). They can form Ca2+-permeable pores through homo-
and heteropolymerization (11, 12). Each subunit is proposed to have two
putative transmembrane helices connected with a large extracellular
loop, and both the N and C termini are located in the cytoplasm. From
their N termini to the second transmembrane domain, the cloned subunits
exhibit a relatively high level of amino acid (aa) sequence homology
compared with their C termini, which are variable in lengths and show
no apparent sequence homology except for the proximal region near the
second transmembrane domain (1). During continuous exposure to agonist,
current signals generated by recombinant P2XRs are desensitized
gradually, an action that should effectively attenuate or terminate
direct and indirect Ca2+ influx.
Based on the observed differences in their current desensitization
kinetics, recombinant P2XRs are generally divided into two groups: the
rapidly desensitizing (P2X1R and P2X3R) and the slowly desensitizing (P2X2R, P2X4R,
P2X5R, P2X6R, and P2X7R) (3). Experiments with chimera subunits composed of P2X2R and
P2X1R or P2X3R subunits suggested that the
rapid desensitization requires interactions between two transmembrane
domains of receptor subunits (13). A large C terminus of
P2X7R has also been suggested to account for the
nondesensitizing pattern of these channels during repetitive
stimulation (10). Recently, a new view of P2XR desensitization has
emerged; the C-terminal splice variant of P2X2R, termed
P2X2bR or P2X2-2R, was found to lack a stretch
of 69 aa and to desensitize faster than the full-length
P2X2R, termed P2X2aR (14-16). Amino acids
responsible for such a functional difference between the spliced and
full-length channels are localized to the initial six residues
(Arg371-Pro376) within the spliced segment
(17).
Here, we examined the importance of the C-terminal 6-aa sequences of
P2XRs, which correspond to Arg371-Pro376 of
P2X2aR (Fig. 1), to the
desensitization pattern of these channels. For this purpose, P2XRs and
their mutants were expressed in GT1 immortalized neurons, and the
impact of receptor desensitization on the pattern of
[Ca2+]i signaling was analyzed by monitoring
single cell [Ca2+]i. These cells are excitable
and express two types of voltage-gated calcium channels, T- and L-type
(18). On the other hand, neither P2XRs nor Ca2+-mobilizing
P2Y receptors are native for these cells (16). Our results indicate
that the pattern of receptor desensitization is unique for each homo-
and heteropolymeric channel and that the structural differences in the
C-terminal small region in part account for such variety of
responses.
Expression Constructs and Site-directed Mutagenesis--
Protein
coding sequences for rat P2X1R (4), P2X3R (6),
P2X4R (19), P2X6R (9), and P2X7R
(10) were obtained by PCR with reverse-transcribed mRNA from heart
(P2X1R), pituitary (P2X3R), and brain
(P2X4R, P2X6R, and P2X7R),
respectively. Total RNA was isolated using TrizolTM reagent
(Life Technologies, Inc) and was treated with DNase I at 37 °C for
30 min. After heat inactivation of DNase I by incubating it at 70 °C
for 15 min, first-strand cDNA was synthesized from 5 µg of total
RNA by Superscript II reverse transcriptase and oligo(dT)12-18 primers in a reaction volume of 20 µl.
The resulting single-strand cDNA (1 µl) was then used as a
template in 25 µl of PCR containing 2 mM each of four
deoxynucleoside triphosphates, 50 mM KCl, 10 mM
Tris-HCl (pH 8.3), 2 mM MgCl2, and 0.5 units of
Ex Taq polymerase (PanVera Corp., Madison WI). Primer
annealing sites were selected from 3'- and 5'-untranslated regions and
had the following sequences: X1 sense, 5'-GGCCGTGTGGGGTGTTCATCTCT-3'; X1 antisense, 5'-TCCAAAGTCTTGCCTGTCTTCAT-3'; X3 sense,
5'-TAAGTGGCTGTGAGCAGTTTCTC-3'; X3 antisense,
5'-GGAAGCATTGCCTATCTGTTGAA-3'; X4 sense, 5'-TGGCGAGGGGACCCACAGTGTC-3'; X4 antisense, 5'-GAGCCGGGCTCCAACAAGATGT-3'; X6 sense,
5'-ACTGGGACCATGGCTTCTGC-3'; X6 antisense,
5'-AACCACTCCTGAGACACCTG-3'; X7 sense, 5'-CCAGGTCCCGCCGAAACAGAGT-3'; and
X7 antisense, 5'-GGCCTAACAATCCCTTCAACAC-3'. In the X6 sense primer, a point mutation (underlined) was introduced to obtain optimum
translation efficiency (20). PCR products were separated on a 1%
agarose gel, recovered, and subcloned into pBluescript II vector
(Stratagene, La Jolla, CA) at its HincII site pretreated with 2'-deoxythymidine and Taq DNA polymerase (Life
Technologies, Inc.). Sequences of subcloned inserts were verified in
both strands with vector- and insert-specific primers using T7
sequenase (U. S. Biochemical Corp.). Confirmed inserts as well as
cDNAs for P2X2aR, P2X2bR, and
P2X5R (16) were transferred to pcDNA 3.1 (Invitrogen,
Carlsbad, CA) at the XhoI/NotI site for mammalian expression.
All C-terminal mutants were made by a PCR-based overlap extension
method (21) using the wild-type receptor cDNA as a template. Entire
PCR fragments carrying mutations were subcloned into pBluescript II,
sequenced, and transferred to C termini of the wild-type expression constructs using the following restriction sites:
ClaI/HindIII, BspEI/HindIII,
PstI/HindIII, and SmaI for
P2X2aR, P2X3R, P2X4R, and
P2X7R mutants, respectively. All restriction enzymes were obtained from New England Biolabs (Beverly, MA). The full-length P2X3R and its chimera mutant with P2X2aR were
transferred from pBluescript to a bicistronic enhanced fluorescent
protein vector, pIRES2-EGFP (CLONTECH, Palo Alto,
CA), at its XhoI/EcoRI site, generating
pIRES/P2XR3 and pIRES/P2X3/X2aR, respectively.
Cell Cultures and Transfection--
GT1 cells were cultured in
Dulbecco's modified Eagle's medium/Ham's F-12 (1:1) containing 10%
(v/v) fetal bovine serum, 100 µg/ml streptomycin, and 100 units/ml
penicillin. Procedures for transient transfection in GT1 cells were
performed as described (17) with minor modifications. Briefly, cells
were plated on coverslips coated with poly-L-lysine at a
density of 0.5-1.0 × 105 cell/35-mm dish and allowed
to grow for 24 h. On the day of transfection, the total amount of
1.2 µg of expression constructs encoding wild-type or mutant P2XRs
was mixed with 8 µl of cationic lipid, LipofectAMINETM,
in 1.2 ml of reduced serum medium, Opti-MEM (Life Technologies, Inc.)
for 15 min at ambient temperature. The DNA mixture was then applied to
cells for 3-5 h and replaced by normal culture medium. The cells were
subjected to experiments 24-48 h after the transfection. For
co-transfection experiments, a ratio of 1:2 DNA for P2X2aR and pIRES constructs was used, keeping the total DNA amount same as above.
[Ca2+]i Measurements--
For single cell
[Ca2+]i measurements, cells were incubated at
37 °C for 60 min with 1 µM fura-2 AM in phenol red-
and ATP-free Dulbecco's modified Eagle's medium. The cells were
subsequently washed with assay buffer containing 137 mM
NaCl, 5 mM KCl, 1.2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES (pH 7.4), and
10 mM glucose and kept for at least 30 min in this medium
before measurements. Apyrase (grade I) was purchased from Sigma and
used at 20 µg/ml throughout the incubation process indicated.
Coverslips with cells were mounted on the stage of an Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany) attached to the Attofluor
digital fluorescence microscopy system (Atto Instruments, Rockville,
MD). [Ca2+]i responses were examined under a 40×
oil immersion objective during exposure to alternating 340- and 380-nm
light beams, and the intensity of light emission at 520 nm was
measured. The ratio of light intensities,
F340/F380, which reflects
changes in [Ca2+]i, was simultaneously followed
in several single cells. Cells expressing fluorescence protein were
optically detected by an emission signal at 520 nm when excited by
488-nm ultraviolet light and were not detectable by 340- or 380-nm
excitations. We thus considered the emission signal from fluorescence
protein by 340- or 380-nm excitations within our background level. In co-transfection experiments of P2X2aR cDNA and pIRES
vectors, about 75% of fluorescent protein-positive cells responded to
100 µM ATP stimulation and were considered to be
co-transfected. Lower co-transfection efficiency below this level
tended to show small response, and such experiments were excluded from
further analysis.
Calculations--
Since transfection efficiencies and expression
levels of recombinant receptors were variable among the cells, only
cells showing the peak [Ca2+]i amplitude of more
than 1.0 in the F340/F380
ratio scale were further used for evaluating the desensitization rates. The time course of [Ca2+]i response to ATP was
fitted to one or two exponential functions using SigmaPlot 5.0 (Jandel
Scientific software, San Rafael, CA) with the tolerance value set at
10 Desensitization Pattern of Homopolymeric P2XRs--
Our previous
results have shown that GT1 cells are a suitable cell model for
analyzing the P2X2aR and P2X2bR desensitization by single cell [Ca2+]i measurements (16, 17).
Here we show that all members of P2XRs, when expressed individually,
responded to 100 µM ATP with a significant rise in
[Ca2+]i. In cells transfected with
P2X1R or P2X3R cDNA, however, preincubation
of cultures with apyrase, an ectonucleotidase that degrades ATP, was
necessary to detect any appreciable [Ca2+]i
change. Preincubation of P2X2aR-expressing cells with this
enzyme did not alter the pattern of [Ca2+]i
response compared with that observed in controls (not shown).
The averaged peak [Ca2+]i amplitudes induced by
supramaximal concentrations of ATP apparently differed among P2XRs. When stimulated with 100 µM ATP, the amplitudes of
[Ca2+]i were comparable among cells expressing
P2X2aR, P2X2bR, and P2X4R, whereas
500 µM ATP was required to reach the comparable [Ca2+]i response in P2X7R-transfected
cells. The peak [Ca2+]i responses caused by
activated P2X1R and P2X3R with 100 µM ATP were about one-third those observed in cultures
expressing P2X2aR. A small fraction (less than 10%) of
cells transfected with P2X5R or P2X6R cDNAs
also responded to 100-500 µM ATP but with the amplitude
of [Ca2+]i responses about one-fifth that seen in
the P2X2aR. Because of such low and variable
[Ca2+]i responses, P2X5R and
P2X6R were not employed in further studies.
As illustrated in Fig. 2A, the
receptors also differed in their capacities to sustain
[Ca2+]i signaling during continuous stimulation
with ATP. The P2X1R- and P2X3R-expressing cells
completely terminated [Ca2+]i signaling within
1-2 min of stimulation with 100 µM ATP. The
[Ca2+]i responses caused by activation of
P2X2bR and P2X4R showed a relatively slow
decrease compared with those generated by the P2X1R and
P2X3R. In contrast, P2X2aR- and
P2X7R-expressing cells induced long-lasting
[Ca2+]i signals. The P2X2aR-induced
[Ca2+]i signals usually decreased to one-third of
maximum response, and this steady-state plateau level was reached
within 10 min of stimulation. The P2X7R-expressing cells
showed no obvious decline in [Ca2+]i response for
more than 10 min. In all cases, except for P2X7R, single
exponential functions were sufficient to describe the decline rates of
[Ca2+]i responses. The mean values of calculated
rate constants are shown in Fig. 2B. The rank order of
desensitization rates derived from these data (P2X1R = P2X3R > P2X2bR > P2X4R > P2X2aR > P2X7R)
was highly comparable with that observed in current measurements (22),
confirming the validity of single cell [Ca2+]i
measurements as a method for comparative evaluation of receptor
desensitization.
Role of a C-terminal 6-aa Sequence in Receptor
Desensitization--
Recently, we found that the
Arg371-Pro376 sequence, located in the
cytoplasmic region of P2X2aR, is necessary for the slow
desensitizing pattern of these receptors (17). As shown in Fig. 1, this
6-aa region is located near the second putative transmembrane domain, and the C-terminal difference in amino acid sequences among the members
of P2XRs starts from this region. To study the possible role of
structural diversity of this region in the control of receptor
desensitization, the Arg371-Pro376 sequence of
P2X2aR was introduced to P2X3R and
P2X4R instead the native
Thr362-Lys367 and
Glu376-Gly381 sequences, respectively. Such
C-terminal chimeric subunits were termed
P2X3/X2aR and P2X4/X2aR
(Figs. 1 and 3). Cells expressing the
P2X3/X2aR mutant responded to 100 µM ATP with an apparent delay in desensitization of
[Ca2+]i signals compared with the wild-type
P2X3R (Fig. 3A). Furthermore, the averaged spike
[Ca2+]i amplitude was significantly higher in
cells expressing P2X3/X2aR than in cells
expressing P2X3R
(F340/F380: 1.6 ± 0.1 (n = 31) versus 2 ± 0.05 (n = 34), respectively). As seen in wild-type P2X3R, the addition of apyrase to the bath solution was
necessary to detect the [Ca2+]i change in
P2X3/X2aR-expressing cells, indicating that sensitivity of P2X3R to ATP was not largely affected by
introducing Arg371-Pro376 sequence to its C
terminus.
Cells expressing P2X4/X2aR also showed a slower
desensitization rate compared with the cells transfected with the
wild-type P2X4R (Fig. 3B). The calculated time
constants for the desensitization rates were 12 ± 2 ms
In further studies, the reverse mutation was performed at
P2X2aR C terminus by substituting the
Arg371-Pro376 sequence for the corresponding
6-aa sequence of P2X3R, P2X4R, and
P2X1R, and the mutant P2X2aR subunits were
termed P2X2a/X3R, P2X2a/X4R, and
P2X2a/X1R, respectively. As shown in Fig.
4, traces b, c, and
d, all chimeric subunits formed functional channels in GT1
cells with enhanced desensitization rates when compared with the
wild-type P2X2aR (trace a). However, none of the
P2X2aR mutants was able to mimic the rate of
P2X2bR desensitization (trace e). In terms of
averaged peak [Ca2+]i amplitudes, no significant
difference in [Ca2+]i responses was observed
between wild-type and mutant P2X2aR.
The relevance of the 6-aa sequence in the control of desensitization in
wild-type and chimeric channels are summarized in Fig. 3C
and Table I. The rate constant for the
desensitization of chimeric P2X4/X2aR was
indistinguishable from that of P2X2aR (Fig. 3B).
Also, no significant differences were observed between P2X4R and P2X2a/X4R (Table I),
indicating that the structural element responsible for the distinct
pattern of P2X2aR and P2X4R desensitization is
localized to the region of the 6-aa C-terminal sequence. In contrast,
the desensitization rates of P2X2a/X1R and
P2X2a/X3R were significantly enhanced by
mutations but not enough to reproduce responses seen in cells
expressing wild-type P2X1R and P2X3R (Table I).
Similarly, the desensitization rate of
P2X3/X2aR was considerably reduced, but not to
the level seen in cells expressing wild-type P2X2aR.
Therefore, a part of the subunit molecule other than the C terminus
also participates in the control of P2X1R and
P2X3R desensitization. This agrees with literature data
(13) suggesting that the transmembrane domains are critical for the
fast desensitization process of P2X1R and P2X3R
signaling.
We have also analyzed the relevance of P2X7R C-terminal
6-aa sequence on receptor desensitization. The optimized results of the
amino acid sequence alignments for P2XRs revealed that
Val392-Pro397 sequence of P2X7R
corresponds to the Arg371-Pro376 sequence of
P2X2aR. However, a 18-aa stretch from Cys362 to
Val379 of P2X7R is not related to any other
subunit C termini. Thus, an insertion was needed in the alignment (1).
Substitution of Val392-Pro397 sequence with the
corresponding Glu376-Gly381 sequence of
P2X4R generated a functional
P2X7/X4R mutant receptor, the
Ca2+-signaling function of which was indistinguishable from
that of wild-type P2X7R. This suggests that the C-terminal
6-aa sequence of P2X7R subunit is not functionally
equivalent to those found in other subunits in terms of controlling
receptor desensitization.
Identification of Residues Contributing to the Receptor
Desensitization--
The in-frame splicing of the P2X2aR C
terminus starts at Val370 (indicated by an arrow
in Fig. 1) and effectively removes three positively charged residues
from the Arg371-Pro376 sequence. On the other
hand, negatively charged residue(s) were found in the corresponding
segment of P2X1R, P2X3R, P2X2bR,
and P2X4R (Fig. 1), and all these receptors apparently
showed faster desensitization than P2X2aR. Such a
structural difference raised the possibility that charged residues in
this region may play an important role in P2XR desensitization. This is
especially relevant for P2X2a/X4R and
P2X4/X2aR mutants, whose desensitization patterns were indistinguishable from the wild type P2X4R
and P2X2aR, respectively.
To test this, we next evaluated the effects of single amino acid
substitution in the P2X4R C terminus on the pattern of
ATP-induced [Ca2+]i response. The negatively
charged residues in the 6-aa sequence of P2X4R were
replaced with neutral ones, or the basic residues of the
Arg371-Pro376 sequence were introduced. As
shown on Fig. 5, both elimination of
negatively charged residues from and introduction of positively charged
residue to the position of Glu376 in P2X4R
decreased the rate of desensitization. Mutation of Glu379
to a basic lysine residue also resulted in a significant decrease in
the rate of desensitization. However, the point mutations at Glu376 or Glu379 could not produce the same
extent of desensitization as seen in cells expressing wild-type
P2X2aR and mutant P2X4/X2aR. In addition, we constructed two mutant P2X4R subunits having
3-aa substitutions, with native acidic moieties of P2X4R
changed to neutral (P2X4E376Q/D377Q/E379Q) or three basic amino acids
of P2X2aR introduced at the corresponding sites of
P2X4R (P2X4RE376R/E379K/Q380H). Both triple mutants
desensitized slower than the wild-type P2X4R (Fig. 5).
Thus, changing the amino acid composition and the net charge of this
particular C-terminal segment altered the duration of Ca2+
influx induced by P2X4R.
Within the Arg371-Pro376 of P2X2aR,
Thr372 represents an optimum phosphorylation site,
(R/K)XX(T/S), for the type II
calcium/calmodulin-dependent protein kinase (23). At the
analogous position of Thr372, either glutamate or aspartate
was found in P2X1R, P2X3R, P2X2bR, and P2X4R (Fig. 1). We speculated that phosphorylation of
the single Thr372 residue or introduction of a negatively
charged moiety at this position may change the desensitization rate of
P2X2aR. However, substitution of this residue with
glutamate or with glutamine did not affect the desensitization rate of
mutant channels compared with that of the wild type. The
desensitization constants for glutamate- and glutamine-containing
mutants were 4 ± 0.3 ms Desensitization Pattern of Heteropolymeric P2XRs--
The
co-expression of P2X2aR and P2X3R has been
shown to form a heteropolymeric P2XR channel, which exhibits a distinct
pharmacological profile and desensitization pattern from those seen in
homopolymeric channels (11, 12). We used this particular subunit
combination to analyze the impact of the C-terminal structure on the
[Ca2+]i-signaling pattern of heteropolymeric
channels. GT1 neurons expressing only P2X3R responded to 20 µM AMP-CPP with a rise in [Ca2+]i,
the amplitude and desensitization rate of which were highly comparable
with that observed in 100 µM ATP-stimulated cells (Fig. 2). When co-expressed, these two subunits generated a
channel that also responded to 20 µM AMP-CPP but with the
amplitude of response comparable with that observed in homopolymeric
P2X2aR stimulated with 100 µM ATP (Fig.
6A). In contrast, cells
co-transfected with an empty vector and cDNA for P2X2aR
did not respond to this agonist (Fig. 6A).
Under the continuous presence of AMP-CPP, the subsequent application of
100 µM ATP further increased
[Ca2+]i, suggesting the existence of two channels
with distinct pharmacological features in a co-transfected cell:
AMP-CPP-sensitive and -insensitive (Fig. 6A). When the
co-transfected cells were initially stimulated with 100 µM ATP, the subsequent addition of 100 µM
AMP-CPP failed to induce any change in [Ca2+]i
(not shown). Therefore, all P2XRs-expressed cells were sensitive to ATP
and desensitized completely during the initial stimulation. This
suggests that the AMP-CPP-mediated rise in
[Ca2+]i was initiated by the activation of
heteropolymeric P2X2aR + P2X3R, which
desensitized more rapidly than the homopolymeric P2X2aR but
slowly when compared with P2X3R (Figs. 2 and 6).
The co-expression of the P2X2aR and C-terminal mutant
P2X3/X2aR also resulted in the formation of
AMP-CPP-sensitive heteropolymeric channels (Fig. 6). However, the
desensitization of [Ca2+]i signals generated by
these channels was significantly slower than in P2X2aR + P2X3R-expressing cells (9.5 ± 0.3 (n = 63) versus 13.5 ± 0.9 (n = 34),
respectively). These results indicate that the C-terminal structure of
the participating subunits influences the desensitization of
heteropolymeric P2X2aR + P2X3R channels in a
manner comparable with that observed in homopolymeric channels. It is
also important to stress that the exact subunit stoichometry of the
heteropolymeric P2X2aR + P2X3R and
P2X2aR + P2X3/X2aR in our
experiments is not known and might vary within the cells. To overcome
the possible impact of such heterogeneity on conclusions driven from
these experiments, the number of recordings from which means were
derived was elevated compared with other experiments (see above).
In this study, we employed GT1 neurons as an expression system to
analyze the impact of receptor desensitization on the
Ca2+-signaling function of recombinant P2XRs and to
identify the role of C terminus in receptor desensitization. The time
scale for [Ca2+]i measurements in our experiments
was set to be sufficiently long (5-10 min) to incorporate the
consequence of a pore dilation effect during ATP stimulation reported
by others (24, 25) on Ca2+ signaling. Under such recording
conditions, activation of all homopolymeric P2XR by ATP caused a rise
in [Ca2+]i, the pattern of which was highly
specific for each particular channel. Receptors differed among
themselves with respect to the amplitude of Ca2+ response.
[Ca2+]i signals initiated by the homopolymeric
P2XRs also desensitized with rates characteristic to each receptor
subtype: P2X1R = P2X3R > P2X2bR > P2X4R > P2X2aR > P2X7R.
The kinetics of receptor desensitization estimated in single cell
[Ca2+]i measurements should be interpreted with
two reservations. First, voltage-gated calcium channels, which are
expressed by GT1 cells (18), were not silenced during
[Ca2+]i recording. Second, although the rank
orders for receptor desensitization estimated in current and
[Ca2+]i measurements were highly comparable, the
time needed to reach the steady desensitized states for P2XRs was
significantly longer when estimated in [Ca2+]i
measurements (22). This probably reflects the slow kinetics of
Ca2+ elimination from the cytoplasm, which was additionally
enhanced by the integration of voltage-gated Ca2+ influx
during receptor stimulation. Thus, [Ca2+]i
recordings are of limited use for studies on the dynamics of channel
behavior, and the calculated rates should be interpreted only as a
relative indicator of the status of receptor desensitization, especially when compared with results obtained in electrophysiological measurements.
However, we previously found a marked and comparable difference in the
desensitization rates of P2X2aR and spliced
P2X2bR in both current recordings and single cell
[Ca2+]i measurements, the later done under
conditions where voltage-gated calcium channels were silent (16). In
addition, the amplitudes of [Ca2+]i response
induced by these channels were significantly reduced when
Ca2+ influx through L-type Ca2+ channels was
blocked by nifedipine, but the estimated rate of receptor
desensitization was not affected (17). Finally, the rank order of
receptor desensitization estimated in [Ca2+]i
measurements was highly comparable to those observed by others in
current measurements for P2X1R, P2X3R,
P2X2aR, P2X2bR, and P2X7R (22).
In our experimental conditions, the rapidly desensitizing
P2X1R and P2X3R were unable to induce a
measurable increase in [Ca2+]i when GT1 cells
were bathed in physiological solution, but the inclusion of apyrase in
extracellular space recovered receptors from the desensitized state.
This suggests that the spontaneous release or pathological leakage of
cellular ATP may prevent the fast-desensitizing receptors from
responding to ATP stimulation with an increase in
[Ca2+]i. P2X4R exhibited fast
desensitization when expressed in oocytes and slow desensitization when
expressed in HEK293 cells (19, 26, 27), indicating that experimental
conditions, including a difference in amphibian and mammalian
expression systems, may change the recombinant channel behavior (24).
In our expression system, P2X4R completely desensitized
during continuous agonist stimulation. With respect to the rate of
desensitization, this channel should be considered as a relatively slow
desensitizing one.
These observations support the validity of
[Ca2+]i measurements as an indicator of P2X
receptor desensitization. Since the pattern of
[Ca2+]i response initiated by P2XRs represents
signals that encode the activity of these receptors for controlling
cellular functions, the time course for desensitization estimated by
single cell [Ca2+]i measurements is highly
relevant. Also, activation of voltage-gated Ca2+ influx is
a physiological mechanism by which P2XRs amplify
[Ca2+]i signals in excitable cells in addition to
conducting Ca2+ through their pores. All together, these
results indicates that selective expression of P2XR subunits in an
excitable cell can serve as an effective mechanism for generating
specific Ca2+ signals.
Our results further indicate that the variable subunit C termini in
part accounts for the observed differences in the desensitization of
channels. The structural element controlling the desensitization pattern of P2X2aR and P2X4R appears to be
exclusively localized to the 6-aa C-terminal sequence. Within the
Arg371-Pro376 of P2X2aR,
Thr372 represents an optimum phosphorylation site,
(R/K)XX(T/S), for type II
calcium/calmodulin-dependent protein kinase and is not present
in P2X4R. Nonetheless, this residue is not responsible for the
difference in the desensitization of these two channels, as documented
in experiments with single amino acid mutations.
It is likely that total net charge in the
Arg371-Pro376 sequence of P2X2aR
and in the equivalent sequences of P2X3R, and
P2X4R is an important determinant of the extent of
Ca2+ influx during sustained ATP stimulation. In a case of
mutant P2X2aR/X4R, the replacement of three
positive net charges with three negative ones in the equivalent segment
increased the rate of desensitization compared with
P2X2a/X1R or P2X2a/X3R
mutant receptors with two and one negative residue, respectively. The relevance of single mutations at the charged residues to
P2X4R desensitization was also confirmed. Both removal of
negatively charged residues and introduction of positive ones resulted
in a significant delay of desensitization. Furthermore, the individual residues in the 6-aa sequence of the P2X4R C terminus were
not exactly equivalent in terms of their effects on receptor
desensitization. Substitution of amino acids closer to the second
transmembrane domain had a more profound impact on the pattern of
[Ca2+]i response. This domain is suggested to
form a pore-lining region of P2XR (3). Since the 6-aa region of P2XR C
termini is located relatively close to the cytoplasmic mouth of the
pore, we may speculate that the electrical charge in the 6-aa region has an influence on the overall efficiency of conformational transition to the desensitized state.
In parallel to electrophysiological measurements (11, 12),
[Ca2+]i measurements showed that
heteropolymerization of P2X2aR and P2X3R
results in a channel sensitive to AMP-CPP, which desensitizes with a
pattern different from those seen in cells expressing homopolymeric channels. The contribution of each subunit C terminus to
[Ca2+]i-signaling profile was additive in this
combination of subunits. Furthermore, desensitization of the
heteropolymeric channels composed of P2X2aR and
P2X3R subunit was delayed by the C-terminal mutation
introduced only in the P2X3R subunit. Based on the putative
pseudosymmetrical orientation of the channel subunits, heteropolymeric
P2X2aR + P2X3R could have the 6-aa C-terminal region of each subunit at an equivalent position around the pore axis.
Such a ring-like structure made by the C-terminal-charged residues
could determine the pattern of P2XR signaling.
In contrast to the other receptor subunits, mutation at the C-terminal
6-aa sequence of P2X7R did not result in modulation of
receptor desensitization. This is not a surprise, since the structure
of P2X7R C terminus is distantly related to others. It is
the longest C terminus among P2XRs and contains the structural basis
underlying the unique feature of this channel, the cell-lytic pore
formation. It also shows the least amino acid sequence similarity compared with the other P2XR C termini (10). The amino acid sequence
alignment of P2XRs revealed that an 18-aa stretch of P2X7R,
with no similarity to others, is positioned proximal to the
Val392-Pro397 sequence, which corresponds to
the Arg371-Pro376 sequence of
P2X2aR (1). This insertion should effectively move the
charged 6-aa residues away from the internal mouth of the pore.
A role of the C terminus in receptor signaling is not unique for P2XRs.
The contribution of the C terminus to channel gating was reported for
other channels, including acetylcholine-gated channels, inward
rectifier potassium channels, and mechano-sensitive channels (28-31).
In the case of inwardly rectifying potassium channels, which have the
same topological architecture as P2XRs, the important determinants of
the pore block by Mg2+ and polyamines are mediated by
negatively charged residues located in the C terminus and the second
transmembrane region (29). The mechanism for P2XR desensitization by
the charged C-terminal small segment needs to be further examined by
means of structural and biophysical studies.
In conclusion, we show here that the activation of P2XRs by ATP leads
to an increase in [Ca2+]i, the pattern of which
is highly specific for each channel expressed and determined by the
rate of receptor desensitization. The variable C termini of receptor
subunits in part account for the observed difference in desensitization
rates of homo- and heteropolymeric receptors. The charged residues in
the 6-aa C-terminal sequence appear to serve as a common factor
influencing the desensitization rates of P2X3R,
P2X2aR, P2X2bR, and P2X4R. The
structural element responsible for the difference in desensitization
rates among P2X2aR, P2X2bR, and
P2X4R is exclusively localized to the 6-aa C-terminal
sequence. In the case of P2X1R and P2X3R
subunits, the structure other than the C termini also participates in
the control of desensitization. Finally, P2X7R has a
distinct C terminus, as well as a distinct pattern of
[Ca2+]i signaling, and further experiments are
required to establish the possible relationship between the structure
of this terminus and the sustained Ca2+ influx.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES

View larger version (24K):
[in a new window]
Fig. 1.
Schematic representation of the P2XR with two
putative transmembrane domain model and amino acid sequences of the
proximal C termini. Shading indicates conserved
residues. In the terminal six-amino acid segments shown, negatively
charged residues are indicated by squares, and positively
charged residues are indicated by circles. The
arrow indicates the beginning of the spliced site in
P2X2aR C terminus. M1 and M2 indicate the transmembrane
domains 1 and 2, and N and C indicate the N and C termini,
respectively.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES
5. Significant differences were determined by either
Student's t test or one-way analysis variance (ANOVA)
followed by Scheffe's test, if applicable; p < 0.05 was considered as significantly different.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES

View larger version (34K):
[in a new window]
Fig. 2.
Pattern of calcium signaling by homopolymeric
P2XRs transiently expressed in GT1 cells. A,
representative tracings of ATP-induced [Ca2+]i
signals, with normalized amplitudes of [Ca2+]i
responses (y axes). The P2X7R-expressing cells
were stimulated with 500 µM ATP, whereas the other
receptor-expressing cells were stimulated with 100 µM
ATP. B, the calculated desensitization rates were derived
from single exponential fittings. The bars shown are the
means ± S.E. derived from the number of trials
indicated above the bars. *, p < 0.05 between
P2X1R/P2X3R and P2X2bR; **,
p < 0.05 between P2X2bR and
P2X4R; and ***, p < 0.05 between
P2X4R and P2X2aR.

View larger version (20K):
[in a new window]
Fig. 3.
Calcium signaling in GT1 cells expressing
chimeric P2XRs bearing the Arg371-Pro376
sequence of P2X2aR. A, pattern of
ATP-induced calcium signals in wild-type P2X3R and mutant
P2X3/X2aR. Cells were stimulated with 100 µM ATP in the presence of 20 µg/ml apyrase.
B, pattern of Ca2+ signaling in cells expressing
wild-type P2X4R and mutant
P2X4/X2aR. The tracings shown in A
and B are computer-derived means from 8-10 single cell
recordings. C, comparison of the desensitization rates for
native and mutant receptors with or without
Arg371-Pro376 sequence. The bars
shown are mean ± S.E. derived from the number of
trials indicated above the bars. *p < 0.05 or higher
among pairs.
1 (n = 12) for P2X4R
versus 4 ± 0.7 ms
1 (n = 12) for P2X4/X2aR. The averaged peak
[Ca2+]i amplitudes induced by 100 µM ATP were elevated in the mutant
P2X4/X2aR compared with wild-type
P2X4R
(F340/F380: 2.1 ± 0.1 (n = 72) and 1.6 ± 0.1 (n = 55), respectively). On the other hand, the half maximal doses of ATP
required to induce maximum peak [Ca2+]i response
were comparable for wild-type and chimeric channels (0.8 and 1.6 µM, respectively), indicating that ATP is equipotent for
both wild-type P2X4R and mutant
P2X4/X2aR.

View larger version (21K):
[in a new window]
Fig. 4.
Calcium signaling in GT1 cells expressing
wild-type and mutant P2X2aR. The tracings
shown are means from at least 18 recordings. The time constants are
shown in Table I.
Desensitization rate of wild-type and mutant P2XR receptors

View larger version (31K):
[in a new window]
Fig. 5.
Desensitization rates of wild-type
P2X4R and its mutant receptors expressed in GT1 cells.
A, negatively charged residues of wild-type
P2X4R (indicated by squares) were substituted
with neutral residues (indicated by shading). B,
the positively charged residues of P2X2aR (indicated by
circles on top bar) were introduced to
P2X4R (indicated by shading). The
bars shown are mean ± S.E. for at least 20 recordings.
The top left bar and dashed lines indicate the
rate of wild-type P2X4R desensitization, whereas the
top right bar and dotted lines indicate mean
values for wild-type P2X2aR desensitization.
Asterisks indicate a significant difference compared with
P2X4R, p < 0.05 or higher.
1 (n = 35)
and 5 ± 0.3 ms
1 (n = 21),
respectively, and 4 ± 0.2 ms
1 (n = 26) for wild-type channels. Also, no obvious difference was observed in
the maximum amplitude of [Ca2+]i response and the
EC50 values for ATP between P2X2aR and each
C-terminal mutant receptors examined (not shown).

View larger version (29K):
[in a new window]
Fig. 6.
Calcium signaling in GT1 cells expressing
heteropolymeric P2XRs. A, pattern of
[Ca2+]i signaling in cells co-transfected with
P2X2aR + vector, P2X2aR + P2X3R, or
P2X2aR + P2X3/X2aR. In chimeric
subunit P2X3/X2aR, the
Thr362-Lys367 sequence of P2X3R was
substituted with Arg371-Pro376 sequence of
P2X2aR. The tracings shown are representative
from 50-80 records obtained in three independent experiments. ATP was
added in cultures already containing AMP-CPP
(
,
-MeATP). B, desensitization rates of
heteropolymeric receptors, calculated from experiments with cells
stimulated with 20 µM AMP-CPP. Bars shown are
means ± S.E., and the asterisk indicates a significant
difference (p < 0.05) between means.
![]()
DISCUSSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSSION
REFERENCES
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Section on Cellular
Signaling, ERRB/NICHD, Bldg. 49, Rm. 6A-36, 49 Convent Dr., Bethesda, MD 20892-4510. Tel.: 301-496-1638; Fax: 301-594-7031; E-mail: stankos@helix.nih.gov.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
P2XR, ATP-gated
receptor channels;
aa, amino acid(s);
PCR, polymerase chain reaction;
AMP-CPP, adenosine 5'-(
,
-methylene)triphosphate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Buell, G., Collo, G., and Rassendren, F. (1996) Eur. J. Neurosci. 8, 2221-2228[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | North, R. A. (1996) Neurosciences 8, 187-194 |
| 3. |
Ralevic, V.,
and Burnstock, G.
(1998)
Pharmacol. Rev.
50,
413-492 |
| 4. | Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., and Buell, G. (1994) Nature 371, 516-519[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Brake, A. J., Wagenbach, M. J., and Julius, D. (1994) Nature 371, 519-523[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Chen, C.-C., Akoplan, A. N., Sivllott, L., Colquhoun, D., Burnstock, G., and Wood, J. N. (1995) Nature 377, 428-431[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Bo, X., Zhang, Y., Nassar, M., Burnstock, G., and Schoepfer, R. (1995) FEBS Lett. 375, 129-133[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Garcia-Guzman, M., Soto, F., Laube, B., and Stuhmer, W. (1996) FEBS Lett. 338, 123-127 |
| 9. |
Collo, G.,
North, R. A.,
Kawashima, E.,
Merlo-Pich, E.,
Neidhart, S.,
Surprenant, A.,
and Buell, G.
(1996)
J. Neurosci.
16,
2495-2507 |
| 10. | Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., and Buell, G. (1996) Science 272, 735-738[Abstract] |
| 11. | Lewis, C., Neidhart, S., Holy, C., North, R. A., Buell, G., and Surprenant, A. (1995) Nature 377, 432-435[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Radford, K. M.,
Virginio, C.,
Surprenant, A.,
North, A.,
and Kawashima, E.
(1997)
J. Neurosci.
17,
6529-6533 |
| 13. |
Werner, P.,
Seward, E. P.,
Buell, G. N.,
and North, R. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15485-15490 |
| 14. | Brandle, U., Spielmanns, P., Osteroth, R., Sim, J., Surprenant, A., Buell, G., Ruppersberg, J. P., Plinkert, P. K., Zenner, H. P., and Glowatzki, E. (1997) FEBS Lett. 404, 294-298[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Simon, J.,
Kidd, E. J.,
Smith, F. M.,
Chessell, I. P.,
Murrell-Lagnado, R.,
Humphrey, P. P. A.,
and Barnard, E. A.
(1997)
Mol. Pharmacol.
52,
237-248 |
| 16. |
Koshimizu, T.,
Tomic, M.,
Van Goor, F.,
and Stojilkovic, S. S.
(1998)
Mol. Endocrinol.
12,
901-913 |
| 17. |
Koshimizu, T.,
Tomic, M.,
Koshimizu, M.,
and Stojilkovic, S. S.
(1998)
J. Biol. Chem.
273,
12853-12857 |
| 18. |
Van Goor, F.,
Krsmanovic, L. Z.,
Catt, K. J.,
and Stojilkovic, S. S.
(1999)
Mol. Endocrinol.
13,
587-603 |
| 19. | Buell, G., Lewis, C., Collo, G., North, R. A., and Surprenant, A. (1996) EMBO J. 15, 55-62[Medline] [Order article via Infotrieve] |
| 20. |
Kozak, M.
(1991)
J. Cell Biol.
115,
887-903 |
| 21. | Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., and Pease, L. R. (1989) Gene 77, 61-68[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Evans, R. J., Surprenant, A., and North, R. A. (1997) in The P2 Nucleotide Receptors (Turner, J. T. , Weisman, G. A. , and Fedan, J. S., eds) , pp. 43-61, Humana Press Inc., Totowa, NJ |
| 23. | Pearson, R. B., and Kemp, B. E. (1991) Methods Enzymol. 200, 62-81[Medline] [Order article via Infotrieve] |
| 24. | Khakh, B. S., Bao, X. R., Labarca, C. & Lester, H. A. (1999) 2, 322-330 |
| 25. | Virginio, C., MacKenzie, A., Rassendren, F. A., North, R. A., and Surprenant. (1999) Nat. Neurosci. 2, 315-321[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Soto, F.,
Garcia-Guzman, M.,
Gomez-Hernandez, J. M.,
Hollmann, M.,
Karschin, C.,
and Stuhmer, W.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3684-3688 |
| 27. |
Seguela, P.,
Haghighi, A.,
Soghomonian, J.,
and Cooper, E.
(1996)
J. Neurosci.
16,
448-455 |
| 28. | Yang, J., Jan, Y. N., and Jan, L. Y. (1995) Neuron 15, 1047-1054 |
| 29. | Pessia, M., Bond, C. T., Kavanaugh, M. P., and Adelman, J. P. (1995) Neuron 14, 1039-1045[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Corringer, P. J., Bertrand, S., Galzi, J. L., Devillers-Thiery, A., Changeux, J. P., and Bertrand, D. (1999) Neuron 22, 831-843[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Chang, G.,
Spencer, R. H.,
Lee, A. T.,
Barclay, M. T.,
and Rees, D. C.
(1998)
Science
282,
2220-2226 |
This article has been cited by other articles:
![]() |
A. del Rey, V. Renigunta, A. H. Dalpke, J. Leipziger, J. E. Matos, B. Robaye, M. Zuzarte, A. Kavelaars, and P. J. Hanley Knock-out Mice Reveal the Contributions of P2Y and P2X Receptors to Nucleotide-induced Ca2+ Signaling in Macrophages J. Biol. Chem., November 17, 2006; 281(46): 35147 - 35155. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujiwara and Y. Kubo Regulation of the desensitization and ion selectivity of ATP-gated P2X2 channels by phosphoinositides J. Physiol., October 1, 2006; 576(1): 135 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fabbretti, M. D'Arco, A. Fabbro, M. Simonetti, A. Nistri, and R. Giniatullin Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J. Neurosci., June 7, 2006; 26(23): 6163 - 6171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Fountain and R. A. North A C-terminal Lysine That Controls Human P2X4 Receptor Desensitization J. Biol. Chem., June 2, 2006; 281(22): 15044 - 15049. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-a. Koshimizu, K. Kretschmannova, M.-L. He, S. Ueno, A. Tanoue, N. Yanagihara, S. S. Stojilkovic, and G. Tsujimoto Carboxyl-Terminal Splicing Enhances Physical Interactions between the Cytoplasmic Tails of Purinergic P2X Receptors Mol. Pharmacol., May 1, 2006; 69(5): 1588 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masin, D. Kerschensteiner, K. Dumke, M. E. Rubio, and F. Soto Fe65 Interacts with P2X2 Subunits at Excitatory Synapses and Modulates Receptor Function J. Biol. Chem., February 17, 2006; 281(7): 4100 - 4108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. STOJILKOVIC, M. TOMIC, M.-L. HE, Z. YAN, T.-A. KOSHIMIZU, and H. ZEMKOVA Molecular Dissection of Purinergic P2X Receptor Channels Ann. N.Y. Acad. Sci., June 1, 2005; 1048(1): 116 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yan, Z. Liang, M. Tomic, T. Obsil, and S. S. Stojilkovic Molecular Determinants of the Agonist Binding Domain of a P2X Receptor Channel Mol. Pharmacol., April 1, 2005; 67(4): 1078 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fabbretti, E. Sokolova, L. Masten, M. D'Arco, A. Fabbro, A. Nistri, and R. Giniatullin Identification of Negative Residues in the P2X3 ATP Receptor Ectodomain as Structural Determinants for Desensitization and the Ca2+-sensing Modulatory Sites J. Biol. Chem., December 17, 2004; 279(51): 53109 - 53115. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zemkova, M.-L. He, T.-a. Koshimizu, and S. S. Stojilkovic Identification of Ectodomain Regions Contributing to Gating, Deactivation, and Resensitization of Purinergic P2X Receptors J. Neurosci., August 4, 2004; 24(31): 6968 - 6978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chaumont, L.-H. Jiang, A. Penna, R. A. North, and F. Rassendren Identification of a Trafficking Motif Involved in the Stabilization and Polarization of P2X Receptors J. Biol. Chem., July 9, 2004; 279(28): 29628 - 29638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rettinger and G. Schmalzing Desensitization Masks Nanomolar Potency of ATP for the P2X1 Receptor J. Biol. Chem., February 20, 2004; 279(8): 6426 - 6433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. He, H. Zemkova, T.-a. Koshimizu, M. Tomic, and S. S. Stojilkovic Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels Am J Physiol Cell Physiol, August 1, 2003; 285(2): C467 - C479. [Abstract] [Full Text] [PDF] |